title: Lymphoma models for B cell activation and tolerance. I. Conditions for the anti-mu-dependent stimulation of growth in NBL, a nude B cell lymphoma.
abstract: NBL is a spontaneous B cell lymphoma that originated in NIH Swiss nude mouse, and has been maintained as an in vitro line for 4 yr in our laboratory. It is surface IgM positive and expresses several B cell markers including Fc receptors, as well as Ly-1. Although clones of NBL will grow in serum-containing medium, this cell line enters a quiescent state in serum-free culture. However, in the presence of affinity-purified or monoclonal anti-mu reagents, NBL increases its rate of proliferation as measured by thymidine incorporation or in absolute cell numbers. This stimulation is specific for mu-chain, because it does not occur with anti-beta 2 microglobulin, irrelevant nonbinding antibodies, or with monoclonal anti-B cell lineage markers. Bivalent anti-mu is required, and no consistent Fc-mediated inhibition of growth has been detected. Stimulation of NBL occurs optimally at critical cell densities (greater than 3 X 10(3)/well) in the absence of serum. Therefore, we reasoned that NBL either produced or was receptive to known B cell growth factors. Although no classic IL 1 was detected in NBL supernatants, some BCGF-I-like activity was found. Finally, in the presence of LPS, both spontaneous and anti-mu-stimulated NBL growth was inhibited, a result suggesting maturation of this lymphoma. These results suggest that NBL represents an excellent model to study the growth and differentiation of B cell subsets.
authors.forename: M
authors.initials: M
authors.lastname: Ling
authors.forename: D
authors.initials: D
authors.lastname: Livnat
authors.forename: P S
authors.initials: PS
authors.lastname: Pillai
authors.forename: D W
authors.initials: DW
authors.lastname: Scott
mesh_terms: D000818:Animals; D000888:Antibodies, Anti-Idiotypic / Q000502:physiology*; D001402:B-Lymphocytes / Q000276:immunology*; D002452:Cell Count; D002460:Cell Line; D004195:Disease Models, Animal; D000939:Epitopes / Q000276:immunology; D007108:Immune Tolerance; D007075:Immunoglobulin M / Q000276:immunology* / Q000378:metabolism; D007375:Interleukin-1 / Q000502:physiology; D008070:Lipopolysaccharides / Q000494:pharmacology; D008213:Lymphocyte Activation; D008223:Lymphoma / Q000276:immunology*; D051379:Mice; D008819:Mice, Nude; D010641:Phenotype; D011947:Receptors, Antigen, B-Cell / Q000145:classification / Q000378:metabolism; D011961:Receptors, Fc / Q000032:analysis / Q000378:metabolism / Q000502:physiology
chemical_list: D000888:Antibodies, Anti-Idiotypic; D000939:Epitopes; D007075:Immunoglobulin M; D007375:Interleukin-1; D008070:Lipopolysaccharides; D011947:Receptors, Antigen, B-Cell; D011961:Receptors, Fc